- UroToday Home
- Urologic Oncology
The Latest Renal Cancer Research
Recent Abstracts
-
Belzutifan for renal cell carcinoma: Balancing regulatory approval with societal and patient impact.Renal CancerJanuary 14, 2025
-
Dynamics of resistance to immunotherapy and TKI in patients with advanced renal cell carcinoma.Renal CancerJanuary 14, 2025
-
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial.Renal CancerJanuary 14, 2025
-
Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal CancRenal CancerJanuary 13, 2025
-
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.Renal CancerJanuary 13, 2025
-
Efficacy and safety of microwave ablation in solitary kidney patients with T1a small renal masses.Renal CancerJanuary 10, 2025
-
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx Renal.Renal CancerJanuary 10, 2025
-
Critical Care Therapy After Cytoreductive Nephrectomy for Metastatic Kidney Cancer.Renal CancerJanuary 10, 2025
-
SARS-CoV-2 Spike Protein Amplifies the Immunogenicity of Healthy Renal Epithelium in the Presence of Renal Cell Carcinoma.Renal CancerJanuary 9, 2025
-
Pre- and post-diagnosis body weight trajectories in patients with localized renal cell cancer.Renal CancerJanuary 9, 2025
Beyond the Abstracts
-
Surgical Experience and Functional Outcomes after Laparoscopic and Robot-Assisted Partial Nephrectomy: Results from a Multi-Institutional Collaboration - Beyond the AbstractRenal CancerJanuary 7, 2025
-
Impact of Tumor Volume and Other Factors on Renal Function After Partial Nephrectomy - Beyond the AbstractRenal CancerDecember 19, 2024
-
Stereotactic Body Radiotherapy (SBRT) for the Treatment of Primary Localized Renal Cell Carcinoma: A Systematic Review and Meta-Analysis - Beyond the AbstractRenal CancerDecember 17, 2024
-
Differences in Mutations Across Tumour Sizes in Clear-Cell Renal Cell Carcinoma - Beyond the AbstractRenal CancerOctober 21, 2024
-
Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1) - Beyond the AbstractRenal CancerOctober 15, 2024
-
Diagnostic Accuracy and Safety of Renal Tumour Biopsy in Patients with Small Renal Masses and Its Impact on Treatment Decisions - Beyond the AbstractRenal CancerOctober 14, 2024
-
A Genetic Basis for Sex Differences in Xp11 Translocation Renal Cell Carcinoma - Beyond the AbstractRenal CancerSeptember 11, 2024
-
International Multicenter Real-World REGistry for Patients with Metastatic renAL Cell Carcinoma - Meet-URO 33 Study (REGAL Study) - Beyond the AbstractRenal CancerSeptember 6, 2024
-
Treatment-Free Survival and Partitioned Survival Analysis of Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab plus Ipilimumab Versus Sunitinib: 5-Year Update of CheckMate 214 - Beyond the AbstractRenal CancerAugust 29, 2024
-
Prognostic Significance of Inflammatory Markers in Patients with Advanced Renal Cell Carcinoma Receiving Nivolumab plus Ipilimumab - Beyond the AbstractRenal CancerAugust 23, 2024